IRIS
ADAMO, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 437
AS - Asia 67
NA - Nord America 63
OC - Oceania 4
Totale 571
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 176
IE - Irlanda 121
US - Stati Uniti d'America 61
FR - Francia 56
VN - Vietnam 50
PL - Polonia 49
DE - Germania 11
IN - India 8
CN - Cina 5
FI - Finlandia 5
AU - Australia 4
NL - Olanda 4
BG - Bulgaria 3
CA - Canada 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
RS - Serbia 2
UA - Ucraina 2
AT - Austria 1
HR - Croazia 1
IR - Iran 1
JP - Giappone 1
LI - Liechtenstein 1
PH - Filippine 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 571
Salva come PNG Salva come JPEG
Città #
Dublin 121
Messina 100
Dong Ket 48
Warsaw 48
Boardman 12
Ashburn 9
Paris 8
Milan 6
Chicago 4
Helsinki 4
Mountain View 4
Bremen 3
Florence 3
Los Angeles 3
New York 3
Washington 3
Amsterdam 2
Breda 2
Catania 2
London 2
Melbourne 2
Milpitas 2
Nadiad 2
Novi Sad 2
Sofia 2
Alassio 1
Aragona 1
Bad Bellingen 1
Bari 1
Brisbane 1
Cleveland 1
Council Bluffs 1
Davao City 1
Delhi 1
Duncan 1
Grassobbio 1
Houston 1
Huế 1
Hyderabad 1
Kashan 1
Konin 1
Landshut 1
Mumbai 1
Naples 1
Ottawa 1
Oulu 1
Padova 1
Palermo 1
Redmond 1
Rome 1
Sarnia 1
Savona 1
Somerville 1
Tappahannock 1
Trieste 1
Tuy Hoa 1
Tübingen 1
Ufa 1
Varna 1
Villeneuve-le-roi 1
Wollongong 1
Totale 433
Salva come PNG Salva come JPEG
Nome #
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study, file de3e52b3-15f5-762d-e053-3705fe0a30e0 41
Negative hyperselection of patients with RAS and BRAF wild-type metastatic colorectal cancer who received panitumumab-based maintenance therapy, file de3e52b3-36d3-762d-e053-3705fe0a30e0 32
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives, file de3e52af-95d1-762d-e053-3705fe0a30e0 30
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial, file de3e52b3-3592-762d-e053-3705fe0a30e0 30
Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario, file de3e52b3-17ae-762d-e053-3705fe0a30e0 29
Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial, file de3e52b3-a946-762d-e053-3705fe0a30e0 28
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients, file de3e52af-8d9f-762d-e053-3705fe0a30e0 27
Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup, file de3e52b0-de06-762d-e053-3705fe0a30e0 21
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going, file de3e52b1-5772-762d-e053-3705fe0a30e0 21
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience, file de3e52b3-a914-762d-e053-3705fe0a30e0 20
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review, file de3e52b1-5302-762d-e053-3705fe0a30e0 19
The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer, file de3e52b3-2091-762d-e053-3705fe0a30e0 19
Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study, file de3e52b3-a944-762d-e053-3705fe0a30e0 19
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel, file de3e52b3-6c91-762d-e053-3705fe0a30e0 18
Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about "Triple-negative breast cancer: treatment challenges and solutions" by Collignon et al, file de3e52b0-2687-762d-e053-3705fe0a30e0 17
An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries, file de3e52b3-95b9-762d-e053-3705fe0a30e0 16
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer, file de3e52b3-cf63-762d-e053-3705fe0a30e0 16
Nab-paclitaxel and trastuzumab combination: A promising approach for neoadjuvant treatment in HER2-positive breast cancer, file de3e52b0-d488-762d-e053-3705fe0a30e0 15
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status, file de3e52b0-d883-762d-e053-3705fe0a30e0 15
The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer, file de3e52b3-6673-762d-e053-3705fe0a30e0 15
Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site, file de3e52b3-8d6a-762d-e053-3705fe0a30e0 15
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer, file de3e52b0-d34d-762d-e053-3705fe0a30e0 14
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients, file de3e52b3-a3c6-762d-e053-3705fe0a30e0 12
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?, file de3e52b3-8fb8-762d-e053-3705fe0a30e0 11
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation, file de3e52b1-5775-762d-e053-3705fe0a30e0 10
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases, file de3e52b3-8fba-762d-e053-3705fe0a30e0 10
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going, file de3e52b3-6268-762d-e053-3705fe0a30e0 6
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC)., file de3e52af-9acb-762d-e053-3705fe0a30e0 5
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme, file de3e52b3-559f-762d-e053-3705fe0a30e0 5
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer, file de3e52b1-4ef4-762d-e053-3705fe0a30e0 4
IL-33/IL-31 axis: A new pathological mechanism for epidermal growth factor receptor tyrosine kinase inhibitors-associated skin toxicity?, file de3e52af-d969-762d-e053-3705fe0a30e0 3
Liquid biopsy tracking of lung tumor evolutions over time, file de3e52b3-7ca7-762d-e053-3705fe0a30e0 3
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice, file de3e52b4-e22d-762d-e053-3705fe0a30e0 3
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study, file 1d416ca8-ee13-4929-bd9a-b35b3ac8328c 2
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery, file 88582e16-e70f-4301-921d-547a81c21a0e 2
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study., file de3e52af-b317-762d-e053-3705fe0a30e0 2
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer., file de3e52b0-fe80-762d-e053-3705fe0a30e0 2
null, file de3e52b1-46e1-762d-e053-3705fe0a30e0 2
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors, file de3e52b1-7f6a-762d-e053-3705fe0a30e0 2
RET fusions in solid tumors, file de3e52b3-4c99-762d-e053-3705fe0a30e0 2
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation, file de3e52b3-5312-762d-e053-3705fe0a30e0 2
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer, file de3e52b3-5428-762d-e053-3705fe0a30e0 2
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation to trastuzumab treatment., file de3e52ae-d0bc-762d-e053-3705fe0a30e0 1
Natural history of malignant bone disease in renal cancer: final results of an italian bone metastasis survey., file de3e52af-ae7d-762d-e053-3705fe0a30e0 1
Emerging targeted therapies for castration-resistant prostate cancer, file de3e52b1-0513-762d-e053-3705fe0a30e0 1
null, file de3e52b3-0a3d-762d-e053-3705fe0a30e0 1
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy, file de3e52b3-0dcb-762d-e053-3705fe0a30e0 1
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis, file de3e52b3-1c2a-762d-e053-3705fe0a30e0 1
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance, file de3e52b3-8fb7-762d-e053-3705fe0a30e0 1
Results From a Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease From Italian Sites, file de3e52b3-9163-762d-e053-3705fe0a30e0 1
Totale 575
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.179
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 0 0 0 2 0 11 18
2020/2021184 13 0 6 16 8 1 4 7 8 66 6 49
2021/202239 0 0 0 1 5 12 9 3 6 2 1 0
2022/2023173 2 1 4 4 4 1 4 5 123 0 24 1
2023/2024120 5 3 13 16 5 2 33 4 29 10 0 0
Totale 575